medigraphic.com
ISSN 1561-3070 (Electronic)

2020, Number 4

<< Back Next >>

Rev Cub Oftal 2020; 33 (4)

Glaucoma and systemic diseases of vascular involvement

Díaz ÁY, Obret MI, Chaviano LG, Fumero GFY, Domínguez RM

Language: Spanish
References: 25
Page: 1-22
PDF size: 514.41 Kb.


ABSTRACT

Intraocular pressure is considered to be the only potentially modifiable causative factor to prevent glaucoma blindness. However, glaucoma is a multifactorial disease, and true as it is that its main risk factor is intraocular pressure, its reduction does not ensure cessation of the progress of glaucomatous damage. Primary open angle glaucoma and normal pressure glaucoma share similar pathogenetic risk factors, and may be classified as mechanical or vascular. According to current scientific evidence, an important association exists between systemic diseases with vascular involvement, such as migraine, obstructive sleep apnea, arterial hypotension of various causes, arterial hypertension, cerebrovascular disease, ischemic heart disease and diabetes mellitus, and ocular findings in patients with glaucomatous optic neuropathy. In view of this correlation, these diseases should be considered jointly, so that visual health professionals always bear in mind the evaluation of their common characteristics and act in consequence. A search was carried out on glaucoma and systemic diseases with vascular compromise.


REFERENCES

  1. Quigley HA, Vitale S. Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci. 1997;38:83-91.

  2. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130(4):429-40.

  3. Musch DC, Gillespie BW, Niziol LM, Lichter PR, Varma R. Intraocular pressure control and long-term visual field loss in the collaborative initial glaucoma treatment study. Ophthalmology. 2011;118(9):1766-73.

  4. Lukas TJ, Du P, Miao H, Lin S. Differencial effects of elevate hydrostatic pressure on gene expresion and protein phosphorylation in optic nerve head astrocytes. En: Kubena Rijeka C, editor. The mystery of glaucoma; 2011. p. 19-40.

  5. Konieczka K, Ritch R, Traverso CE, et al. Flammer syndrome. EPMA J. 2014;5:2.

  6. Konieczka K, Fränkl S, Todorova MG, Henrich PB. Unstable oxygen supply and glaucoma. Klin Monatsb Augenheilk. 2014;231(2):121-6.

  7. Goadsby PJ. Recent advances in the diagnosis and management of migraine. Br Med J. 2006;332:25-9.

  8. Phelps CD, Corbett JJ. Migraine and low-tension glaucoma. A case-control study. IOVS. 1985;26:1105-8.

  9. De Vivero C, Ruiz A, Urrea-Victoria T, Hidalgo-Martínez P, Briceño-Montoya M. Prevalencia de glaucoma en pacientes con síndrome de apnea hipoapnea obstructiva del sueño. Hospital San Ignacio de Bogotá; 2016.

  10. Caprioli J, Colemn AL. Blood pressure, perfusion pressure and glaucoma. Am J Ophthalmol. 2010;149:704-12.

  11. Charlson ME, de Moraes CG, Link A, et al. Nocturnal systemic hypotension increases the risk of glaucoma progression. Ophthalmology. 2014;121(10):2004-12.

  12. Voichanski S, Grossman C, Leibowitz A, et al. Orthostatic hypotension is associated with nocturnal change in systolic blood pressure. Am J Hypert. 2012;25(2):159-64.

  13. Gilbert-Lucido ME, García-Huerta M, Ruiz-Quintero N, et al. Estudio epidemiológico de glaucoma en población mexicana. Rev Mex Oftalmol. 2010;84:86-90.

  14. Zhao D, Cho J, Kim MH, Guallar E. The association of blood pressure and primary open-angle glaucoma: a meta-analysis. Am J Ophthalmol. 2014;158(3):615-27.

  15. Caprioli J, Colemn AL. Blood pressure, perfusion pressure and glaucoma. Am J Ophthalmol. 2010;149:704-12.

  16. Erb C, Predel HG. Relevance of arterial hypertension in primary open-angle glaucoma. Klin Monbl Augenh. 2014;231:136-43.

  17. Redheuil A, Yu WC, Wu CO, et al. Reduced ascending aortic strain and distensibility: earliest manifestations of vascular aging in humans. Hypertension. 2010;55(2):319-26.

  18. Graham SL, Butlin M, Lee M, Avolio AP. Central blood pressure, arterial waveform analysis, and vascular risk factors in glaucoma. J Glauc. 2013;22(2):98-103.

  19. Jau Der H, Chao Chien H, Herng Ching L. Open angle glaucoma and the risk of stroke development. Stroke. 2009;40:2685-90.

  20. Lin HC, Chien CW, Hu CC, Ho JD. Comparison of comorbid conditions between open-angle glaucoma patients and a control cohort: a case-control study. Ophalmology. 2010;117:2088-95.

  21. Rey BN, Varela E, Alba Y, Bibianes MC, García M. Glaucoma y retinopatía en pacientes con diabetes mellitus. MEDISAN. 2007 [acceso: 28/10/2012];11(2). Disponible en: http://bvs.sld.cu/revistas/san/vol11_2_07/san07207.htm

  22. Lee PP, Feldman ZW, Ostermann J, Brown DS, Sloan FA. Longitudinal prevalence of major eye diseases. Arch Ophthalmol. 2003;121(9):1303-10.

  23. Goldich Y, Barkana Y, Gerber Y, Rasko A, Morad Y, Harstein M, et al. Effect of diabetes mellitus on biomechanical parameters of the cornea. J Cataract Refract Surg. 2009;35(4):715-9.

  24. Williams PD, He Y, Konner KS, Mitchell K. The suppresive effect of glaucoma on diabetic retinophaty. IOVS. 2004;45(Suppl. 2):367.

  25. Sato T, Roy S. Effect of high glucose on fibronectin expression and cell proliferation in trabecular meshwork cells. IOVS. 2002;43:170-5.




2020     |     www.medigraphic.com